FI922312A - DIRECTIVE OF CONSTRUCTION. - Google Patents

DIRECTIVE OF CONSTRUCTION. Download PDF

Info

Publication number
FI922312A
FI922312A FI922312A FI922312A FI922312A FI 922312 A FI922312 A FI 922312A FI 922312 A FI922312 A FI 922312A FI 922312 A FI922312 A FI 922312A FI 922312 A FI922312 A FI 922312A
Authority
FI
Finland
Prior art keywords
directive
construction
Prior art date
Application number
FI922312A
Other languages
Finnish (fi)
Other versions
FI922312A0 (en
Inventor
Julie Frances Hoffman
Janet Black Callahan
Charles Hermas Swope
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of FI922312A0 publication Critical patent/FI922312A0/en
Publication of FI922312A publication Critical patent/FI922312A/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/84Systems specially adapted for particular applications
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745Assays involving non-enzymic blood coagulation factors
    • G01N2333/75Fibrin; Fibrinogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Plasma & Fusion (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FI922312A 1989-12-01 1992-05-21 DIRECTIVE OF CONSTRUCTION. FI922312A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44394889A 1989-12-01 1989-12-01
PCT/US1990/006988 WO1991008460A1 (en) 1989-12-01 1990-11-30 Direct fibrinogen assay

Publications (2)

Publication Number Publication Date
FI922312A0 FI922312A0 (en) 1992-05-21
FI922312A true FI922312A (en) 1992-05-21

Family

ID=23762843

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922312A FI922312A (en) 1989-12-01 1992-05-21 DIRECTIVE OF CONSTRUCTION.

Country Status (9)

Country Link
EP (1) EP0502103A4 (en)
JP (1) JPH05503008A (en)
KR (1) KR920704117A (en)
AU (1) AU641459B2 (en)
CA (1) CA2068221A1 (en)
FI (1) FI922312A (en)
IE (1) IE904244A1 (en)
WO (1) WO1991008460A1 (en)
ZA (1) ZA909564B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5708591A (en) * 1995-02-14 1998-01-13 Akzo Nobel N.V. Method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions
US6429017B1 (en) 1999-02-04 2002-08-06 Biomerieux Method for predicting the presence of haemostatic dysfunction in a patient sample
US6898532B1 (en) 1995-06-07 2005-05-24 Biomerieux, Inc. Method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
US6321164B1 (en) 1995-06-07 2001-11-20 Akzo Nobel N.V. Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade
US6502040B2 (en) 1997-12-31 2002-12-31 Biomerieux, Inc. Method for presenting thrombosis and hemostasis assay data
AU774889B2 (en) 1999-02-04 2004-07-08 Biomerieux, Inc. A method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
US7179612B2 (en) 2000-06-09 2007-02-20 Biomerieux, Inc. Method for detecting a lipoprotein-acute phase protein complex and predicting an increased risk of system failure or mortality
CN110257475B (en) * 2019-06-28 2023-05-02 深圳市国赛生物技术有限公司 Fibrinogen detection reagent, preparation method thereof and detection reagent product

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3432268A (en) * 1964-08-28 1969-03-11 Peter Unger Method and apparatus for testing cell suspensions
US3658480A (en) * 1970-04-13 1972-04-25 Bio Data Corp Coagulation timing apparatus, and method
US3833864A (en) * 1972-11-30 1974-09-03 R Kiess Digital direct reading colorimeter
US3861877A (en) * 1974-01-21 1975-01-21 Clinical Technology Inc Optical analysis of fluids
US3905769A (en) * 1974-02-28 1975-09-16 Bagley Wallace E Method and apparatus for measuring prothrombin time and the like
US3989382A (en) * 1975-01-22 1976-11-02 Bio-Data Corporation Platelet aggregation monitoring device
EP0059277A1 (en) * 1981-03-02 1982-09-08 J. & P. Coats, Limited Rapid quantative measurement of fibrinogen in blood plasma
AT382971B (en) * 1981-06-16 1987-05-11 Hoffmann La Roche METHOD AND DEVICE FOR MEASURING THE BLOOD CLUTTING TIME
GB8426004D0 (en) * 1984-10-15 1984-11-21 Ortho Diagnostic Systems Inc Coagulation monitoring
IT1209604B (en) * 1984-11-27 1989-08-30 Instrumentation Lab Spa METHOD AND EQUIPMENT FOR MEASUREMENT OF COAGULATION PARAMETERS.

Also Published As

Publication number Publication date
AU6898391A (en) 1991-06-26
KR920704117A (en) 1992-12-19
FI922312A0 (en) 1992-05-21
WO1991008460A1 (en) 1991-06-13
ZA909564B (en) 1992-11-25
AU641459B2 (en) 1993-09-23
EP0502103A1 (en) 1992-09-09
JPH05503008A (en) 1993-05-27
IE904244A1 (en) 1991-06-05
CA2068221A1 (en) 1991-06-02
EP0502103A4 (en) 1993-05-05

Similar Documents

Publication Publication Date Title
FI902257A0 (en) FOERFARANDE FOER KONTROLLERING AV LUFTINNESLUTNINGAR I BETONGKOMPOSITION.
FI880364A0 (en) DIRECTIVE FUNDING.
NO875061L (en) CASTED CONSTRUCTION PARTS.
FI892709A0 (en) TURBULENSGENERATOR I INLOPPSLAODAN AV EN PAPPERSMASKIN.
FI892385A0 (en) MUNSTYCKESSYSTEM I BLAOSNINGSLAODAN AV EN PAPPERSMASKIN.
FI922312A (en) DIRECTIVE OF CONSTRUCTION.
FI903697A0 (en) FOERFARANDE FOER KONTROLERING AV AVSKILJNINGSKRAFT I AVSKILJBARA BEKLAEDNADER.
FI920423A0 (en) EXTENSION OF MEASURES.
DE3863112D1 (en) DIRECTIVE.
FI921874A (en) SECRETARY E. COLI-STAMMAR.
FI904357A0 (en) FOERFARANDE FOER AKTIVERING AV PROTEIN C.
FI891284A0 (en) FOERFARANDE FOER TILLVERKNING AV CEMENT ELLER BETONG.
FI895219A0 (en) FOERFARANDE FOER FOERPACKNING AV OEVERLAONGA PAPPERS- OCH KARTONGRULLOR I OMSLAGSPAPPER.
FI902791A0 (en) ANORDNING FOER FORMNING AV EN FUKTIG PAPPERSBANA I EN PAPPERSMASKIN.
DE69001506D1 (en) CEMENT STRUCTURES.
FI903597A0 (en) ANORDNING FOER FOERSTAERKNING AV LJUSSIGNALER I OPTISKA FIBERTRANSMISSIONSLINJER.
NO894722D0 (en) TENNA SCHEME.
ES2019251A4 (en) PRODUCTION OF ALPHA-CHLORINE-ALPHA-OXIMINO-4-HYDROXYL ACETOFENONE.
FI892380A0 (en) ANORDING FOER FOERFLYTTNING I SIDLED AV EN RULLE INGAOENDE I EN FOERFLYTTNINGSANORDNING.
ES1008944Y (en) DISPOSITION OF CONSTRUCTION OF WALLS-BOXES.
ES1009426Y (en) SECRETARY.
FI882548A0 (en) VAERMEELEMENT AV KASSETTYP FOER DIREKT ELUPPVAERMNING.
FI906144A0 (en) MODIFICATION OF PLASMINOGENAKTIVATORER.
IT1228800B (en) SKYLIGHT STRUCTURE.
ATE80879T1 (en) HYDROXYFURANONE MANUFACTURE.

Legal Events

Date Code Title Description
FD Application lapsed